-->

Ascendas REIT - CGS-CIMB Research 2021-05-05: Acquiring Balance 75% Stake In Galaxis

ASCENDAS REAL ESTATE INV TRUST (SGX:A17U) | SGinvestors.io ASCENDAS REAL ESTATE INV TRUST (SGX:A17U)

Ascendas REIT - Acquiring Balance 75% Stake In Galaxis

  • Ascendas REIT has acquired the remaining 75% stake in Galaxis for S$534.4m.
  • The purchase is partly funded by a S$420m private placement exercise.
  • Reiterate ADD with a higher DDM-based target price of S$3.31.



Ascendas REIT buys remaining 75% stake in Galaxis

  • Ascendas REIT (SGX:A17U) announced the purchase of the remaining 75% stake in Galaxis from its sponsor for a purchase consideration of S$534.4m or at an initial property yield of 5.3% (post transaction cost). This is based on an agreed property value of S$720m (on a 100% basis), which is at a 2% discount to the average of valuers’ valuation.
  • Galaxis is located in the strategic one-North area, which houses key growth sectors such as bio-medical sciences, infocomm technologies, R&D institutes and start-ups. The property has a net lettable area of 60,935 sq m and enjoys a high occupancy of 98.6% with a weighted average lease expiry of 2.4 years.


Boosting exposure to Singapore business parks segment

  • The purchase will expand Ascendas REIT’s asset base to S$15.79bn and increase its exposure to business parks to 49% of AUM. This will likely enable Ascendas REIT to cater to demand from the technology, biomedical, R&D and new economy industries.
  • Post the acquisition, rental contributions from infocomm technology and electronics tenants are expected to rise to 18.3% of portfolio rental income, according to management. It will also deepen its focus in Singapore to 62% of AUM from 59% previously.


Acquisition is partly funded by fund raising, deal is DPU accretive

  • The total acquisition cost of S$543.8m will be funded by a S$420m fund raising exercise via a private placement of 142.664m new Ascendas REIT units at S$2.944 as well as by taking on its 75% stake of existing bank loans totaling S$161.6m.
  • The purchase is DPU- and book NAV-accretive and could raise DPU and book NAV by 0.4% and 0.9%, respectively, based on management’s proforma estimates.

Reiterate ADD rating






LOCK Mun Yee CGS-CIMB Research | EING Kar Mei CFA CGS-CIMB Research | https://www.cgs-cimb.com 2021-05-05
SGX Stock Analyst Report ADD MAINTAIN ADD 3.31 UP 3.300



Advertisement



MOST TALKED ABOUT STOCKS / REITS OF THE WEEK



loading.......



ANALYSTS SAY


loading.......